Resapp Health

Resapp Health Accounts Payable

The Accounts Payable of Resapp Health (RAP.AX) as of Oct 10, 2026 is 218,929.00 AUD. In the previous year, Accounts Payable was 132,524.00 AUD — a change of 65.20% (higher).

Accounts Payable

218,929.00AUD

YoY

65.20%

Last updated:

Accounts Payable of Resapp Health is 2024 218,929.00 AUD. Accounts Payable of Resapp Health was 2023 132,524.00 AUD. It decreases by 65.20% higher compared to the previous year.

The Resapp Health Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2017
402,272.00 AUD
Jan 1, 2018
524,514.00 AUD
Jan 1, 2019
591,874.00 AUD
Jan 1, 2020
358,302.00 AUD
Jan 1, 2021
334,394.00 AUD
Jan 1, 2022
956,247.00 AUD
Jan 1, 2023
132,524.00 AUD
Jan 1, 2024
218,929.00 AUD
The Resapp Health Accounts Payable history
YEARAccounts PayableYoY
218,929.00AUD+65.20%
132,524.00AUD-86.14%
956,247.00AUD+185.96%
334,394.00AUD-6.67%
358,302.00AUD-39.46%
591,874.00AUD+12.84%
524,514.00AUD+30.39%
402,272.00AUD+150.62%
160,513.00AUD-58.80%
389,620.00AUD+80.99%
215,269.00AUD—
Access this data via the Eulerpool API

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Resapp Health stock

Accounts Payable of Resapp Health is 218,929.00 AUD in 2024.

Accounts Payable of Resapp Health changed from 132,524.00 AUD to 218,929.00 AUD, representing a 65.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Resapp Health since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Resapp Health historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Resapp Health

All Key Metrics — Resapp Health